The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. It includes also the administration of excessive medication. Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs administered to the same patient, must be differentiated from DRUG COMBINATIONS, single preparations containing two or more drugs as a fixed dose, and from DRUG THERAPY, COMBINATION, two or more drugs administered separately for a combined effect. (From Segen, Dictionary of Modern Medicine, 1992)
The practice of administering medications in a manner that poses more risk than benefit, particularly where safer alternatives exist.
The utilization of drugs as reported in individual hospital studies, FDA studies, marketing, or consumption, etc. This includes drug stockpiling, and patient drug profiles.
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
A muscarinic antagonist that has effects in both the central and peripheral nervous systems. It has been used in the treatment of arteriosclerotic, idiopathic, and postencephalitic parkinsonism. It has also been used to alleviate extrapyramidal symptoms induced by phenothiazine derivatives and reserpine.
The formal process of obtaining a complete and accurate list of each patient's current home medications including name, dosage, frequency, and route of administration, and comparing admission, transfer, and/or discharge medication orders to that list. The reconciliation is done to avoid medication errors.
Facilities which provide nursing supervision and limited medical care to persons who do not require hospitalization.
Dibenzothiazepines are a class of heterocyclic chemical compounds that contain a dibenzothiazepine ring structure, which have been used in the development of various pharmaceutical drugs, particularly as tranquilizers, muscle relaxants, and anticonvulsants, but their use has declined due to side effects and the development of newer drugs.
Directions written for the obtaining and use of DRUGS.
The action of a drug that may affect the activity, metabolism, or toxicity of another drug.
The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.
Agents that improve the ability to carry out activities such as athletics, mental endurance, work, and resistance to stress. The substances can include PRESCRIPTION DRUGS; DIETARY SUPPLEMENTS; phytochemicals; and ILLICIT DRUGS.
Care over an extended period, usually for a chronic condition or disability, requiring periodic, intermittent, or continuous care.
Patterns of practice related to diagnosis and treatment as especially influenced by cost of the service requested and provided.
A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions.
Evaluation of the level of physical, physiological, or mental functioning in the older population group.
Errors in prescribing, dispensing, or administering medication with the result that the patient fails to receive the correct drug or the indicated proper drug dosage.
A generalized seizure disorder characterized by recurrent major motor seizures. The initial brief tonic phase is marked by trunk flexion followed by diffuse extension of the trunk and extremities. The clonic phase features rhythmic flexor contractions of the trunk and limbs, pupillary dilation, elevations of blood pressure and pulse, urinary incontinence, and tongue biting. This is followed by a profound state of depressed consciousness (post-ictal state) which gradually improves over minutes to hours. The disorder may be cryptogenic, familial, or symptomatic (caused by an identified disease process). (From Adams et al., Principles of Neurology, 6th ed, p329)
Therapy with two or more separate preparations given for a combined effect.
Drugs used for their effects on the respiratory system.
Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.
The self administration of medication not prescribed by a physician or in a manner not directed by a physician.
A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent.
Medicines that can be sold legally without a DRUG PRESCRIPTION.
Services for the diagnosis and treatment of diseases in the aged and the maintenance of health in the elderly.
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
The design, completion, and filing of forms with the insurer.
Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
Geriatric long-term care facilities which provide supervision and assistance in activities of daily living with medical and nursing services when required.
Excessive, under or unnecessary utilization of health services by patients or physicians.

Clinical resistance patterns and responses to two sequential protease inhibitor regimens in saquinavir and reverse transcriptase inhibitor-experienced persons. (1/332)

The efficacy of sequential protease inhibitor therapy was studied in 16 human immunodeficiency virus (HIV) 1-infected persons in whom saquinavir with multiple nucleoside reverse transcriptase (RT) inhibitors (NRTI) had failed. Nelfinavir plus two NRTIs (new or continued) resulted in minimal (0.59 log RNA copies/mL) and transient (8 weeks) suppression of plasma HIV RNA levels. Rapid failure was surprisingly associated with baseline presence of protease gene mutation L90M (P=.04) in the absence of D30N and with RT mutations D67N (P<.01), K70R/S (P=.02), and K219Q/W/R/E (P<.01). Ten patients were subsequently switched to indinavir plus nevirapine and 2 NRTIs, resulting in a median 1.62 log reduction in plasma HIV RNA, with 3 patients maintaining 400 copies/mL for 24 weeks. These results suggest that nelfinavir may have limited utility after saquinavir failure, particularly without potent concomitant therapy. Combining an NRTI with a new protease inhibitor for rescue may improve response.  (+info)

Polypharmacy in general practice: differences between practitioners. (2/332)

BACKGROUND: Polypharmacy, the simultaneous use of multiple drugs, is associated with adverse drug reactions, medication errors, and increased risk of hospitalization. When the number of concurrently used drugs totals five or more (major polypharmacy), a significant risk may be present. AIM: To analyse the interpractice variation in the prevalence of major polypharmacy among listed patients, and to identify possible predictors of major polypharmacy related to the practice. METHOD: Prescription data were retrieved from the Odense Pharmacoepidemiological Database, and individuals subject to major polypharmacy were identified. The age- and sex-standardized prevalence rate of major polypharmacy was calculated for each practice in the County of Funen in Denmark (n = 173), using the distribution of age and sex of the background population as a reference. The practice characteristics were retrieved from the Regional Health Insurance System. Possible predictors of major polypharmacy related to the general practitioners (GPs) were analysed using backward stepwise linear multiple regression. RESULTS: A six-fold variation between the practices in the prevalence of major polypharmacy was found (16 to 96 per 1000 listed patients; median = 42). Predictors related to the practice structure, workload, clinical work profile, and prescribing profile could explain 56% of the variation. CONCLUSION: A substantial part of the variation in major polypharmacy between practices can be explained by predictors related to practice.  (+info)

Inhibition of epidermal growth factor receptor-associated tyrosine phosphorylation in human carcinomas with CP-358,774: dynamics of receptor inhibition in situ and antitumor effects in athymic mice. (3/332)

Phosphorylation of tyrosine residues on the epidermal growth factor (EGF) receptor (EGFr) is an important early event in signal transduction, leading to cell replication for major human carcinomas. CP-358,774 is a potent and selective inhibitor of the EGFr tyrosine kinase and produces selective inhibition of EGF-mediated tumor cell mitogenesis. To assess the pharmacodynamic aspects of EGFr inhibition, we devised an ex vivo enzyme-linked immunosorbent assay for quantification of EGFr-specific tyrosine phosphorylation in human tumor tissue specimens obtained from xenografts growing s.c. in athymic mice. When coupled with pharmacokinetic analyses, this measurement can be used to describe the extent and duration of kinase inhibition in vivo. CP-358,774 is an effective, orally active inhibitor of EGFr-specific tyrosine phosphorylation (ED(50) = 10 mg/kg, single dose). It has a significant duration of action, producing, on average, a 70% reduction in EGFr-associated phosphotyrosine over a 24-h period after a single 100 mg/kg dose. Inhibition of EGFr phosphotyrosine in an ex vivo assay format effectively estimates the potency and degree of inhibition of EGFr-dependent human LICR-LON-HN5 head and neck carcinoma tumor growth. Substantial growth inhibition of human tumor xenografts was achieved with p.o. doses of the compound (ED(50) = 10 mg/kg q.d. for 20 days). Combination chemotherapy with cisplatin produced a significant response above that of cisplatin alone with no detectable effects on body weight or lethal toxicity. Taken together, these observations suggest that CP-358,774 may be useful for the treatment of EGFr-driven human carcinomas.  (+info)

Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry. (4/332)

The progression of congestive heart failure (CHF) is left ventricular (LV) myocardial remodeling. The matrix metalloproteinases (MMPs) contribute to tissue remodeling and therefore MMP inhibition may serve as a useful therapeutic target in CHF. Angiotensin converting enzyme (ACE) inhibition favorably affects LV myocardial remodeling in CHF. This study examined the effects of specific MMP inhibition, ACE inhibition, and combined treatment on LV systolic and diastolic function in a model of CHF. Pigs were randomly assigned to five groups: 1) rapid atrial pacing (240 beats/min) for 3 weeks (n = 8); 2) ACE inhibition (fosinopril, 2.5 mg/kg b.i.d. orally) and rapid pacing (n = 8); 3) MMP inhibition (PD166793 2 mg/kg/day p.o.) and rapid pacing (n = 8); 4) combined ACE and MMP inhibition (2.5 mg/kg b.i.d. and 2 mg/kg/day, respectively) and rapid pacing (n = 8); and 5) controls (n = 9). LV peak wall stress increased by 2-fold with rapid pacing and was reduced in all treatment groups. LV fractional shortening fell by nearly 2-fold with rapid pacing and increased in all treatment groups. The circumferential fiber shortening-systolic stress relation was reduced with rapid pacing and increased in the ACE inhibition and combination groups. LV myocardial stiffness constant was unchanged in the rapid pacing group, increased nearly 2-fold in the MMP inhibition group, and was normalized in the ACE inhibition and combination treatment groups. Increased MMP activation contributes to the LV dilation and increased wall stress with pacing CHF and a contributory downstream mechanism of ACE inhibition is an effect on MMP activity.  (+info)

Polypharmacy management in Medicare managed care: changes in prescribing by primary care physicians resulting from a program promoting medication reviews. (5/332)

OBJECTIVE: To examine the effects of medication reviews by primary care physicians on prescriptions written for elderly members of a Medicare managed care organization who were at risk for polypharmacy. STUDY DESIGN: Prospective study with follow-up survey. PATIENTS AND METHODS: We conducted a study in 1995 to demonstrate the prevalence of polypharmacy (defined as receiving 5 or more prescription medications during the 3-month study period) among elderly members of our managed care organization. Two years later, elderly members identified as being at risk for polypharmacy were sent a letter encouraging them to schedule a medication review with their primary care physician. Each primary care physician was provided with clinical practice guidelines on polypharmacy and patient-specific medication management reports. Patients and physicians were subsequently mailed a survey to assess the impact of the medication review program on prescribing practices. RESULTS: Of 37,372 elderly members screened, 5737 (15%) were at risk for polypharmacy. Of these, 2615 (46%) responded to the follow-up survey. Of the survey respondents, 1087 (42%) had gone to their primary care physician for a medication review. During the review, 96% of patients discussed their prescription medications and 72% discussed nonprescription medications they were taking. Twenty percent reported that their physician discontinued medications, 29% reported that the physician changed the dose of a medication, and 17% informed their physician about a new prescription or nonprescription medication they were taking. Of the 275 primary care physicians surveyed, 56 (20%) returned the questionnaire. Of these, 61% reported that the medication review program was "very" or "somewhat useful." Thirty-five percent reported discontinuing unnecessary medications, and 23% reported decreasing the frequency of dosing. Overall, 45% of physicians reported making at least one change in their prescribing to a member at risk for polypharmacy. CONCLUSIONS: Our program promoting medication reviews between primary care physicians and their elderly patients resulted in significant changes in prescribing by physicians. This type of program is likely to decrease the risk of polypharmacy among older members of a Medicare managed care organization.  (+info)

Drug interactions and the statins. (6/332)

Drug interactions commonly occur in patients receiving treatment with multiple medications. Most interactions remain unrecognized because drugs, in general, have a wide margin of safety or because the extent of change in drug levels is small when compared with the variation normally seen in clinical therapy. All drug interactions have a pharmacokinetic or pharmacodynamic basis and are predictable given an understanding of the pharmacology of the drugs involved. Drugs most liable to pose problems are those having concentration-dependent toxicity within, or close to, the therapeutic range; those with steep dose-response curves; those having high first-pass metabolism or those with a single, inhibitable route of elimination. Knowing which drugs possess these intrinsic characteristics, together with a knowledge of hepatic P-450 metabolism and common enzyme-inducing and enzyme-inhibiting drugs, can greatly assist physicians in predicting interactions that may be clinically relevant. This article reviews the pharmacology of drug interactions that can occur with hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) to illustrate the scope of the problem and the ways in which physicians may manage this important therapeutic class of drugs.  (+info)

Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels. (7/332)

Gabapentin has been administered in placebo-controlled studies with a thrice daily (T.I.D.) schedule, because of its short half-life. However, clinical efficacy does not seem strictly related to plasma levels: a twice daily (B.I.D.) schedule might therefore be possible. The aim of our study was to verify if the conversion from a T.I.D. to a B.I.D. regimen affected the efficacy and safety of gabapentin therapy. Out of 171 patients treated with add-on gabapentin, we selected 29 stable responders, who were followed for three months with a T.I.D. schedule and then switched to B.I.D. regimen for further three months. Seizure number, side-effects and trough plasma levels of gabapentin were collected during both periods. Gabapentin mean dose was 2117.2 mg/day. Mean number of seizures/months was: 4.2 at baseline, 1.0 during the T.I.D., and 0.9 during the B.I.D. period. Mean trough plasma level of gabapentin was 5.9 microgram/ml during the T.I.D. and 5.2 microgram/ml during the B.I.D. period. Twelve side-effects were reported by 11 patients during the T.I.D. and 6 by 5 patients during the B.I.D. period., sedation and vertigo were the most frequent in both. Results of our study suggest that gabapentin can be administered safely and effectively either with a T.I.D. and a B.I.D. regimen.  (+info)

Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. (8/332)

AIMS: To explore drug exposure, frequency of adverse drug reactions (ADRs), types of ADRs, predisposing risk factors and ADR-related excess hospital stay in medical inpatients. METHODS: Structured data regarding patient characteristics, 'events' (symptoms, laboratory results), diagnoses (ICD10) and drug therapy were collected using a computer-supported data entry system and an interface for data retrieval from electronic patient records. ADR data were collected by 'event monitoring' to minimize possible bias by the drug monitor. The causality of each event was assessed in relation to disease(s) and drug therapy. RESULTS: The analysis included 4331 (100%) hospitalizations. The median observation period was 8 days. The median number of different drugs administered per patient and day was 6 and varied between 4 (Q1 ) and 9 (Q3 ) different drugs in 50% of all hospital days. In 41% of all hospitalizations at least one disease-unrelated event could be possibly attributed to drug therapy. Clinically relevant ADRs occurred in 11% of all hospitalizations. In 3.3% of all hospitalizations ADRs were the cause of hospital admission. The incidence of possibly ADR-related deaths was 1.4. Factors predisposing for clinically relevant ADRs were female gender and polypharmacy. ADR-related excess hospital stay accounted for 8. 6% of hospital days. CONCLUSIONS: These data demonstrate the feasibility of the developed 'event monitoring' system for quantitative analysis of ADRs in medical inpatients. With increasing numbers of recorded patients the pharmacoepidemiological database provides a valuable tool to study specific questions regarding drug efficacy and safety in hospitalized patients.  (+info)

Polypharmacy is the use of multiple medications by a patient, especially when too many forms of medication are used by a patient, inappropriately or, when there is a lack of indication for some of the drugs used. It is often seen in elderly patients who may be prescribed numerous medications by different healthcare providers that can increase the risk of adverse drug reactions, interactions, and impaired cognitive function. The term does not necessarily have a negative connotation, as polypharmacy can also refer to the complex process of managing multiple chronic conditions with appropriate medication therapy. However, it is often used to describe a situation where the number of medications being taken by a patient poses a significant risk to their health.

Inappropriate prescribing is a term used to describe the prescription of medications that are not indicated, are not at the correct dose, or have potential adverse effects outweighing their benefits for a particular patient. This can include prescribing medications for indications not approved by regulatory authorities (off-label use), using incorrect dosages, and failing to consider potential drug interactions or contraindications. Inappropriate prescribing can lead to medication errors, adverse drug reactions, increased healthcare costs, and reduced therapeutic effectiveness, posing a significant patient safety concern.

Drug utilization refers to the use of medications by patients or healthcare professionals in a real-world setting. It involves analyzing and evaluating patterns of medication use, including prescribing practices, adherence to treatment guidelines, potential duplications or interactions, and outcomes associated with drug therapy. The goal of drug utilization is to optimize medication use, improve patient safety, and minimize costs while achieving the best possible health outcomes. It can be studied through various methods such as prescription claims data analysis, surveys, and clinical audits.

Drug-related side effects and adverse reactions refer to any unintended or harmful outcome that occurs during the use of a medication. These reactions can be mild or severe and may include predictable, known responses (side effects) as well as unexpected, idiosyncratic reactions (adverse effects). Side effects are typically related to the pharmacologic properties of the drug and occur at therapeutic doses, while adverse reactions may result from allergic or hypersensitivity reactions, overdoses, or interactions with other medications or substances.

Side effects are often dose-dependent and can be managed by adjusting the dose, frequency, or route of administration. Adverse reactions, on the other hand, may require discontinuation of the medication or treatment with antidotes or supportive care. It is important for healthcare providers to monitor patients closely for any signs of drug-related side effects and adverse reactions and to take appropriate action when necessary.

Antipsychotic agents are a class of medications used to manage and treat psychosis, which includes symptoms such as delusions, hallucinations, paranoia, disordered thought processes, and agitated behavior. These drugs work by blocking the action of dopamine, a neurotransmitter in the brain that is believed to play a role in the development of psychotic symptoms. Antipsychotics can be broadly divided into two categories: first-generation antipsychotics (also known as typical antipsychotics) and second-generation antipsychotics (also known as atypical antipsychotics).

First-generation antipsychotics, such as chlorpromazine, haloperidol, and fluphenazine, were developed in the 1950s and have been widely used for several decades. They are generally effective in reducing positive symptoms of psychosis (such as hallucinations and delusions) but can cause significant side effects, including extrapyramidal symptoms (EPS), such as rigidity, tremors, and involuntary movements, as well as weight gain, sedation, and orthostatic hypotension.

Second-generation antipsychotics, such as clozapine, risperidone, olanzapine, quetiapine, and aripiprazole, were developed more recently and are considered to have a more favorable side effect profile than first-generation antipsychotics. They are generally effective in reducing both positive and negative symptoms of psychosis (such as apathy, anhedonia, and social withdrawal) and cause fewer EPS. However, they can still cause significant weight gain, metabolic disturbances, and sedation.

Antipsychotic agents are used to treat various psychiatric disorders, including schizophrenia, bipolar disorder, major depressive disorder with psychotic features, delusional disorder, and other conditions that involve psychosis or agitation. They can be administered orally, intramuscularly, or via long-acting injectable formulations. The choice of antipsychotic agent depends on the individual patient's needs, preferences, and response to treatment, as well as the potential for side effects. Regular monitoring of patients taking antipsychotics is essential to ensure their safety and effectiveness.

Psychotropic drugs, also known as psychoactive drugs, are a class of medications that affect the function of the central nervous system, leading to changes in consciousness, perception, mood, cognition, or behavior. These drugs work by altering the chemical neurotransmitters in the brain, such as dopamine, serotonin, and norepinephrine, which are involved in regulating mood, thought, and behavior.

Psychotropic drugs can be classified into several categories based on their primary therapeutic effects, including:

1. Antipsychotic drugs: These medications are used to treat psychosis, schizophrenia, and other related disorders. They work by blocking dopamine receptors in the brain, which helps reduce hallucinations, delusions, and disordered thinking.
2. Antidepressant drugs: These medications are used to treat depression, anxiety disorders, and some chronic pain conditions. They work by increasing the availability of neurotransmitters such as serotonin, norepinephrine, or dopamine in the brain, which helps improve mood and reduce anxiety.
3. Mood stabilizers: These medications are used to treat bipolar disorder and other mood disorders. They help regulate the ups and downs of mood swings and can also be used as adjunctive treatment for depression and anxiety.
4. Anxiolytic drugs: Also known as anti-anxiety medications, these drugs are used to treat anxiety disorders, panic attacks, and insomnia. They work by reducing the activity of neurotransmitters such as GABA, which can help reduce anxiety and promote relaxation.
5. Stimulant drugs: These medications are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. They work by increasing the availability of dopamine and norepinephrine in the brain, which helps improve focus, concentration, and alertness.

It is important to note that psychotropic drugs can have significant side effects and should only be used under the close supervision of a qualified healthcare provider.

Biperiden is an anticholinergic drug, which is primarily used to treat symptoms of Parkinson's disease such as stiffness, tremors, spasms, and poor muscle control. It works by blocking the action of a certain natural substance (acetylcholine) in the body. Biperiden can also be used to treat related conditions such as drooling, loss of bladder control, and movement disorders caused by certain medications.

Biperiden may also be used for purposes not listed in its medical product label, as determined by a doctor. It is available in immediate-release and extended-release tablets and oral solution forms. Common side effects include dizziness, drowsiness, dry mouth, blurred vision, and difficulty urinating. Serious side effects are rare but may include hallucinations, irregular heartbeat, and mental/mood changes.

It is important to follow the instructions of a healthcare professional when taking biperiden, as it can interact with other medications and have potentially serious side effects if not used properly.

Medication reconciliation is the process of creating and maintaining an accurate list of all medications a patient is taking, including the name, dosage, frequency, and route, and comparing it to the current medication orders to ensure they are appropriate and safe. This process is used to prevent medication errors such as omissions, duplications, dosing errors, or drug interactions that can occur when patients transfer from one care setting to another (e.g., hospital to home) or when new medications are added. Medication reconciliation aims to reduce adverse drug events and improve patient safety by ensuring that the right medications are given at the right time, in the right dose, and for the right reason. It is typically performed by healthcare professionals such as physicians, pharmacists, and nurses.

A nursing home, also known as a skilled nursing facility, is a type of residential healthcare facility that provides round-the-clock care and assistance to individuals who require a high level of medical care and support with activities of daily living. Nursing homes are designed for people who cannot be cared for at home or in an assisted living facility due to their complex medical needs, mobility limitations, or cognitive impairments.

Nursing homes provide a range of services, including:

1. Skilled nursing care: Registered nurses and licensed practical nurses provide 24-hour medical care and monitoring for residents with chronic illnesses, disabilities, or those recovering from surgery or illness.
2. Rehabilitation services: Physical, occupational, and speech therapists help residents regain strength, mobility, and communication skills after an injury, illness, or surgery.
3. Personal care: Certified nursing assistants (CNAs) help residents with activities of daily living, such as bathing, dressing, grooming, and using the bathroom.
4. Meals and nutrition: Nursing homes provide three meals a day, plus snacks, and accommodate special dietary needs.
5. Social activities: Recreational programs and social events are organized to help residents stay active and engaged with their peers.
6. Hospice care: Some nursing homes offer end-of-life care for residents who require palliative or comfort measures.
7. Secure environments: For residents with memory impairments, specialized units called memory care or Alzheimer's units provide a secure and structured environment to help maintain their safety and well-being.

When selecting a nursing home, it is essential to consider factors such as the quality of care, staff-to-resident ratio, cleanliness, and overall atmosphere to ensure the best possible experience for the resident.

Dibenzothiazepines are a class of heterocyclic chemical compounds that contain a dibenzothiazepine ring structure. This structure is composed of a benzene ring fused to a thiazepine ring, which is itself formed by the fusion of a benzene ring and a diazepine ring (a seven-membered ring containing two nitrogen atoms).

In the medical field, dibenzothiazepines are known for their pharmacological properties and have been used in the development of various drugs. Some dibenzothiazepine derivatives exhibit antipsychotic, anxiolytic, and anticonvulsant activities. However, due to their potential for adverse effects and the availability of safer alternatives, they are not widely used in clinical practice today.

It is important to note that specific dibenzothiazepine compounds may have unique properties and uses beyond their general classification as a chemical class. Always consult medical literature or healthcare professionals for accurate information on specific drugs or compounds.

A drug prescription is a written or electronic order provided by a licensed healthcare professional, such as a physician, dentist, or advanced practice nurse, to a pharmacist that authorizes the preparation and dispensing of a specific medication for a patient. The prescription typically includes important information such as the patient's name and date of birth, the name and strength of the medication, the dosage regimen, the duration of treatment, and any special instructions or precautions.

Prescriptions serve several purposes, including ensuring that patients receive the appropriate medication for their medical condition, preventing medication errors, and promoting safe and effective use of medications. They also provide a legal record of the medical provider's authorization for the pharmacist to dispense the medication to the patient.

There are two main types of prescriptions: written prescriptions and electronic prescriptions. Written prescriptions are handwritten or printed on paper, while electronic prescriptions are transmitted electronically from the medical provider to the pharmacy. Electronic prescriptions are becoming increasingly common due to their convenience, accuracy, and security.

It is important for patients to follow the instructions provided on their prescription carefully and to ask their healthcare provider or pharmacist any questions they may have about their medication. Failure to follow a drug prescription can result in improper use of the medication, which can lead to adverse effects, treatment failure, or even life-threatening situations.

A drug interaction is the effect of combining two or more drugs, or a drug and another substance (such as food or alcohol), which can alter the effectiveness or side effects of one or both of the substances. These interactions can be categorized as follows:

1. Pharmacodynamic interactions: These occur when two or more drugs act on the same target organ or receptor, leading to an additive, synergistic, or antagonistic effect. For example, taking a sedative and an antihistamine together can result in increased drowsiness due to their combined depressant effects on the central nervous system.
2. Pharmacokinetic interactions: These occur when one drug affects the absorption, distribution, metabolism, or excretion of another drug. For example, taking certain antibiotics with grapefruit juice can increase the concentration of the antibiotic in the bloodstream, leading to potential toxicity.
3. Food-drug interactions: Some drugs may interact with specific foods, affecting their absorption, metabolism, or excretion. An example is the interaction between warfarin (a blood thinner) and green leafy vegetables, which can increase the risk of bleeding due to enhanced vitamin K absorption from the vegetables.
4. Drug-herb interactions: Some herbal supplements may interact with medications, leading to altered drug levels or increased side effects. For instance, St. John's Wort can decrease the effectiveness of certain antidepressants and oral contraceptives by inducing their metabolism.
5. Drug-alcohol interactions: Alcohol can interact with various medications, causing additive sedative effects, impaired judgment, or increased risk of liver damage. For example, combining alcohol with benzodiazepines or opioids can lead to dangerous levels of sedation and respiratory depression.

It is essential for healthcare providers and patients to be aware of potential drug interactions to minimize adverse effects and optimize treatment outcomes.

Drug therapy, also known as pharmacotherapy, refers to the use of medications to treat, cure, or prevent a disease or disorder. It is a crucial component of medical treatment and involves the prescription, administration, and monitoring of drugs to achieve specific therapeutic goals. The choice of drug therapy depends on various factors, including the patient's age, sex, weight, overall health status, severity of the condition, potential interactions with other medications, and personal preferences.

The goal of drug therapy is to alleviate symptoms, reduce the risk of complications, slow down disease progression, or cure a disease. It can be used as a standalone treatment or in combination with other therapies such as surgery, radiation therapy, or lifestyle modifications. The effectiveness of drug therapy varies depending on the condition being treated and the individual patient's response to the medication.

Drug therapy requires careful monitoring to ensure its safety and efficacy. Patients should be informed about the potential benefits and risks associated with the medication, including side effects, contraindications, and interactions with other drugs or foods. Regular follow-up appointments with healthcare providers are necessary to assess the patient's response to the therapy and make any necessary adjustments.

In summary, drug therapy is a medical intervention that involves the use of medications to treat, cure, or prevent diseases or disorders. It requires careful consideration of various factors, including the patient's individual needs and preferences, and ongoing monitoring to ensure its safety and effectiveness.

Performance-enhancing substances (PES) are drugs or medications that are used to improve physical or mental performance, stamina, or recovery. These substances can include anabolic steroids, human growth hormone, stimulants, and other compounds that affect various physiological processes in the body. They are often used by athletes, soldiers, and others looking to gain a competitive edge, but their use can also have serious health consequences and is often prohibited in certain competitions or activities. It's important to note that the use of performance-enhancing substances without a prescription from a licensed medical professional is generally considered unethical and against the rules in most sports organizations.

Long-term care (LTC) is a term used to describe various medical and support services that are required by individuals who need assistance with activities of daily living (such as bathing, dressing, using the toilet) or who have chronic health conditions that require ongoing supervision and care. LTC can be provided in a variety of settings, including nursing homes, assisted living facilities, adult day care centers, and private homes.

The goal of LTC is to help individuals maintain their independence and quality of life for as long as possible, while also ensuring that they receive the necessary medical and support services to meet their needs. LTC can be provided on a short-term or long-term basis, depending on the individual's needs and circumstances.

LTC is often required by older adults who have physical or cognitive limitations, but it can also be needed by people of any age who have disabilities or chronic illnesses that require ongoing care. LTC services may include nursing care, therapy (such as occupational, physical, or speech therapy), personal care (such as help with bathing and dressing), and social activities.

LTC is typically not covered by traditional health insurance plans, but it may be covered by long-term care insurance policies, Medicaid, or other government programs. It's important to plan for LTC needs well in advance, as the cost of care can be significant and can have a major impact on an individual's financial resources.

Physician's practice patterns refer to the individual habits and preferences of healthcare providers when it comes to making clinical decisions and managing patient care. These patterns can encompass various aspects, such as:

1. Diagnostic testing: The types and frequency of diagnostic tests ordered for patients with similar conditions.
2. Treatment modalities: The choice of treatment options, including medications, procedures, or referrals to specialists.
3. Patient communication: The way physicians communicate with their patients, including the amount and type of information shared, as well as the level of patient involvement in decision-making.
4. Follow-up care: The frequency and duration of follow-up appointments, as well as the monitoring of treatment effectiveness and potential side effects.
5. Resource utilization: The use of healthcare resources, such as hospitalizations, imaging studies, or specialist consultations, and the associated costs.

Physician practice patterns can be influenced by various factors, including medical training, clinical experience, personal beliefs, guidelines, and local availability of resources. Understanding these patterns is essential for evaluating the quality of care, identifying potential variations in care, and implementing strategies to improve patient outcomes and reduce healthcare costs.

Schizophrenia is a severe mental disorder characterized by disturbances in thought, perception, emotion, and behavior. It often includes hallucinations (usually hearing voices), delusions, paranoia, and disorganized speech and behavior. The onset of symptoms typically occurs in late adolescence or early adulthood. Schizophrenia is a complex, chronic condition that requires ongoing treatment and management. It significantly impairs social and occupational functioning, and it's often associated with reduced life expectancy due to comorbid medical conditions. The exact causes of schizophrenia are not fully understood, but research suggests that genetic, environmental, and neurodevelopmental factors play a role in its development.

Aminosalicylic acids are a group of medications that contain a chemical structure related to salicylic acid, which is the active ingredient in aspirin. These medications are primarily used to treat inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. The most common aminosalicylates used for IBD include mesalamine, sulfasalazine, and olsalazine.

These drugs work by reducing the production of chemicals in the body that cause inflammation in the lining of the intestines. By decreasing inflammation, they can help alleviate symptoms such as diarrhea, abdominal pain, and rectal bleeding associated with IBD. Additionally, aminosalicylates may also have a protective effect on the lining of the intestines, helping to prevent further damage.

Aminosalicylates are available in various forms, including tablets, capsules, suppositories, and enemas, depending on the specific medication and the location of the inflammation within the digestive tract. While these medications are generally well-tolerated, they can cause side effects such as headache, nausea, vomiting, and abdominal pain in some individuals. It is essential to follow the prescribing physician's instructions carefully when taking aminosalicylates to ensure their safe and effective use.

A geriatric assessment is a comprehensive, multidimensional evaluation of an older adult's functional ability, mental health, social support, and overall health status. It is used to identify any medical, psychological, or social problems that could affect the person's ability to live independently and safely, and to develop an individualized plan of care to address those issues.

The assessment typically includes a review of the person's medical history, medications, cognitive function, mobility, sensory function, nutrition, continence, and mood. It may also include assessments of the person's social support network, living situation, and financial resources. The goal of the geriatric assessment is to help older adults maintain their independence and quality of life for as long as possible by addressing any issues that could put them at risk for disability or institutionalization.

Medication errors refer to preventable events that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the healthcare professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems, including prescribing; order communication; product labeling, packaging, and nomenclature; compounding; dispensing; distribution; administration; education; monitoring; and use.

Medication errors can occur at any stage of the medication process, including ordering, transcribing, dispensing, administering, and monitoring. They can result from various factors such as poor communication, lack of knowledge, distractions, confusing drug names or labels, and inadequate systems for preventing errors. Medication errors can lead to adverse drug events, which can cause patient harm, including temporary or permanent disability, and even death.

Tonic-clonic epilepsy, also known as grand mal epilepsy, is a type of generalized seizure that affects the entire brain. This type of epilepsy is characterized by two distinct phases: the tonic phase and the clonic phase.

During the tonic phase, which usually lasts for about 10-20 seconds, the person loses consciousness and their muscles stiffen, causing them to fall to the ground. This can result in injuries if the person falls unexpectedly or hits an object on the way down.

The clonic phase follows immediately after the tonic phase and is characterized by rhythmic jerking movements of the limbs, face, and neck. These movements are caused by alternating contractions and relaxations of the muscles and can last for several minutes. The person may also lose bladder or bowel control during this phase.

After the seizure, the person may feel tired, confused, and disoriented. They may also have a headache, sore muscles, and difficulty remembering what happened during the seizure.

Tonic-clonic epilepsy can be caused by a variety of factors, including genetics, brain injury, infection, or stroke. It is typically diagnosed through a combination of medical history, physical examination, and diagnostic tests such as an electroencephalogram (EEG) or imaging studies. Treatment may include medication, surgery, or dietary changes, depending on the underlying cause and severity of the seizures.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Respiratory system agents are substances that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These agents can be classified into different categories based on their effects:

1. Respiratory Stimulants: Agents that increase respiratory rate or depth by acting on the respiratory center in the brainstem.
2. Respiratory Depressants: Agents that decrease respiratory rate or depth, often as a side effect of their sedative or analgesic effects. Examples include opioids, benzodiazepines, and barbiturates.
3. Bronchodilators: Agents that widen the airways (bronchioles) in the lungs by relaxing the smooth muscle around them. They are used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Examples include albuterol, ipratropium, and theophylline.
4. Anti-inflammatory Agents: Agents that reduce inflammation in the airways, which can help relieve symptoms of asthma, COPD, and other respiratory conditions. Examples include corticosteroids, leukotriene modifiers, and mast cell stabilizers.
5. Antitussives: Agents that suppress coughing, often by numbing the throat or acting on the cough center in the brainstem. Examples include dextromethorphan and codeine.
6. Expectorants: Agents that help thin and loosen mucus in the airways, making it easier to cough up and clear. Examples include guaifenesin and iodinated glycerol.
7. Decongestants: Agents that narrow blood vessels in the nose and throat, which can help relieve nasal congestion and sinus pressure. Examples include pseudoephedrine and phenylephrine.
8. Antimicrobial Agents: Agents that kill or inhibit the growth of microorganisms such as bacteria, viruses, and fungi that can cause respiratory infections. Examples include antibiotics, antiviral drugs, and antifungal agents.

A Drug Utilization Review (DUR) is a systematic retrospective examination of a patient's current and past use of medications to identify medication-related problems, such as adverse drug reactions, interactions, inappropriate dosages, duplicate therapy, and noncompliance with the treatment plan. The goal of DUR is to optimize medication therapy, improve patient outcomes, reduce healthcare costs, and promote safe and effective use of medications.

DUR is typically conducted by pharmacists, physicians, or other healthcare professionals who review medication records, laboratory results, and clinical data to identify potential issues and make recommendations for changes in medication therapy. DUR may be performed manually or using automated software tools that can analyze large datasets of medication claims and electronic health records.

DUR is an important component of medication management programs in various settings, including hospitals, long-term care facilities, managed care organizations, and ambulatory care clinics. It helps ensure that patients receive the right medications at the right doses for the right indications, and reduces the risk of medication errors and adverse drug events.

Self-medication is the use of medications or other healthcare products by individuals to treat self-diagnosed disorders or symptoms, without consulting a healthcare professional. This may include using leftover prescription medications, over-the-counter drugs, or alternative therapies. While it might seem convenient and cost-effective, self-medication can lead to incorrect diagnosis, inappropriate treatment, masking of serious conditions, potential drug interactions, dependency, and complications, which may result in further health issues. It is always recommended to seek professional medical advice before starting any medication or therapy.

Clozapine is an atypical antipsychotic medication that is primarily used to treat schizophrenia in patients who have not responded to other antipsychotic treatments. It is also used off-label for the treatment of severe aggression, suicidal ideation, and self-injurious behavior in individuals with developmental disorders.

Clozapine works by blocking dopamine receptors in the brain, particularly the D4 receptor, which is thought to be involved in the development of schizophrenia. It also has a strong affinity for serotonin receptors, which contributes to its unique therapeutic profile.

Clozapine is considered a medication of last resort due to its potential side effects, which can include agranulocytosis (a severe decrease in white blood cell count), myocarditis (inflammation of the heart muscle), seizures, orthostatic hypotension (low blood pressure upon standing), and weight gain. Because of these risks, patients taking clozapine must undergo regular monitoring of their blood counts and other vital signs.

Despite its potential side effects, clozapine is often effective in treating treatment-resistant schizophrenia and has been shown to reduce the risk of suicide in some patients. It is available in tablet and orally disintegrating tablet formulations.

Nonprescription drugs, also known as over-the-counter (OTC) drugs, are medications that can be legally purchased without a prescription from a healthcare professional. They are considered safe and effective for treating minor illnesses or symptoms when used according to the directions on the label. Examples include pain relievers like acetaminophen and ibuprofen, antihistamines for allergies, and topical treatments for skin conditions. It is still important to follow the recommended dosage and consult with a healthcare provider if there are any concerns or questions about using nonprescription drugs.

"Health services for the aged" is a broad term that refers to medical and healthcare services specifically designed to meet the unique needs of elderly individuals. According to the World Health Organization (WHO), health services for the aged should be "age-friendly" and "person-centered," meaning they should take into account the physical, mental, and social changes that occur as people age, as well as their individual preferences and values.

These services can include a range of medical and healthcare interventions, such as:

* Preventive care, including vaccinations, cancer screenings, and other routine check-ups
* Chronic disease management, such as treatment for conditions like diabetes, heart disease, or arthritis
* Rehabilitation services, such as physical therapy or occupational therapy, to help elderly individuals maintain their mobility and independence
* Palliative care and end-of-life planning, to ensure that elderly individuals receive compassionate and supportive care in their final days
* Mental health services, including counseling and therapy for conditions like depression or anxiety
* Social services, such as transportation assistance, meal delivery, or home care, to help elderly individuals maintain their quality of life and independence.

Overall, the goal of health services for the aged is to promote healthy aging, prevent disease and disability, and provide high-quality, compassionate care to elderly individuals, in order to improve their overall health and well-being.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

Risperidone is an atypical antipsychotic medication that is primarily used to treat certain mental/mood disorders (such as schizophrenia, bipolar disorder, and irritability associated with autistic disorder). It works by helping to restore the balance of certain natural substances in the brain. Risperidone belongs to a class of drugs called benzisoxazole derivatives.

This medication can decrease aggression and schizophrenic symptoms such as hallucinations, delusional thinking, and hostility. It may also help to improve your mood, thoughts, and behavior. Some forms of risperidone are also used for the treatment of irritability in children and adolescents with autistic disorder (a developmental disorder that affects communication and behavior).

It's important to note that this is a general medical definition, and the use of risperidone should always be under the supervision of a healthcare professional, as it can have potential side effects and risks.

Insurance claim reporting is the process of informing an insurance company about a potential claim that an insured individual or business intends to make under their insurance policy. This report typically includes details about the incident or loss, such as the date, time, location, and type of damage or injury, as well as any relevant documentation, such as police reports or medical records.

The purpose of insurance claim reporting is to initiate the claims process and provide the insurance company with the necessary information to evaluate the claim and determine coverage. The insured individual or business may be required to submit additional information or evidence to support their claim, and the insurance company will conduct an investigation to assess the validity and value of the claim.

Prompt and accurate reporting of insurance claims is important to ensure that the claim is processed in a timely manner and to avoid any potential delays or denials of coverage based on late reporting. It is also important to provide complete and truthful information during the claims process, as misrepresentations or false statements can lead to claim denials or even fraud investigations.

Psychotic disorders are a group of severe mental health conditions characterized by distorted perceptions, thoughts, and emotions that lead to an inability to recognize reality. The two most common symptoms of psychotic disorders are hallucinations and delusions. Hallucinations are when a person sees, hears, or feels things that aren't there, while delusions are fixed, false beliefs that are not based on reality.

Other symptoms may include disorganized speech, disorganized behavior, catatonic behavior, and negative symptoms such as apathy and lack of emotional expression. Schizophrenia is the most well-known psychotic disorder, but other types include schizoaffective disorder, delusional disorder, brief psychotic disorder, shared psychotic disorder, and substance-induced psychotic disorder.

Psychotic disorders can be caused by a variety of factors, including genetics, brain chemistry imbalances, trauma, and substance abuse. Treatment typically involves a combination of medication, therapy, and support services to help manage symptoms and improve quality of life.

Pharmaceutical preparations refer to the various forms of medicines that are produced by pharmaceutical companies, which are intended for therapeutic or prophylactic use. These preparations consist of an active ingredient (the drug) combined with excipients (inactive ingredients) in a specific formulation and dosage form.

The active ingredient is the substance that has a therapeutic effect on the body, while the excipients are added to improve the stability, palatability, bioavailability, or administration of the drug. Examples of pharmaceutical preparations include tablets, capsules, solutions, suspensions, emulsions, ointments, creams, and injections.

The production of pharmaceutical preparations involves a series of steps that ensure the quality, safety, and efficacy of the final product. These steps include the selection and testing of raw materials, formulation development, manufacturing, packaging, labeling, and storage. Each step is governed by strict regulations and guidelines to ensure that the final product meets the required standards for use in medical practice.

I couldn't find a specific medical definition for "Homes for the Aged," as it is more commonly referred to in social work or public health contexts. However, I can provide you with some related information:

"Homes for the Aged" are typically residential facilities designed to provide housing, support services, and care for older adults, often with lower levels of medical needs compared to nursing homes. These facilities might offer assistance with activities of daily living (ADLs) such as bathing, dressing, grooming, and managing medications. They can be an alternative to aging in place or moving in with family members.

In a broader public health context, "Homes for the Aged" may fall under the category of congregate housing or assisted living facilities. These settings aim to promote social interaction, autonomy, and independence while offering help with daily tasks and ensuring the safety of their residents.

It is essential to research and visit various facilities to ensure they meet individual needs, preferences, and healthcare requirements when considering Homes for the Aged for yourself or a loved one.

Health services misuse is not a term that has a specific medical definition. However, it generally refers to the inappropriate or unnecessary use of health services, resources, or treatments. This can include overutilization, underutilization, or incorrect utilization of healthcare services. Examples may include ordering unnecessary tests or procedures, using emergency department services for non-urgent conditions, or failing to seek timely and appropriate medical care when needed. Health services misuse can result in harm to patients, increased healthcare costs, and decreased efficiency in the delivery of healthcare services.

In many cases, polypharmacy cannot be avoided, but appropriate polypharmacy practices are encouraged to decrease the risk of ... Poorer health is a strong predictor of polypharmacy at any age, although it is unclear whether the polypharmacy causes the ... About 21% of adults with intellectual disability are also exposed to polypharmacy. The level of polypharmacy has been ... The term polypharmacy is often defined as regularly taking five or more medicines but there is no standard definition and the ...
... polypharmacy - are common among the elderly. Studies have found an association of polypharmacy with adverse outcomes. An ... important question is, to what extent does polypharmacy cause bad outcomes? And, if its causal, what can be done? Read my ... An important question is, to what extent does polypharmacy cause bad outcomes? And, if its causal, what can be done? ... Multiple chronic conditions and the taking of many prescription medications to treat them - polypharmacy - are common among the ...
No polypharmacy. Polypharmacy. No polypharmacy. Polypharmacy. No polypharmacy. Polypharmacy. No polypharmacy. Polypharmacy. No ... Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease. ... Percentage of patients reporting problems on the 5 EQ-5D-5L dimensions, by whether patient reported polypharmacy, defined in ... Percentage of patients reporting problems on the 5 EQ-5D-5L dimensions, by whether patient reported polypharmacy, defined in ...
Polypharmacy in Different Health Settings. As mentioned above, polypharmacy refers to the use of multiple drugs from different ... Additionally, polypharmacy has been reported to have effects on a patients nutritional status. In older adults, polypharmacy ... of subjects had polypharmacy. Notably, the group with the lowest rate of polypharmacy was patients aged 85 years or older (34.8 ... Polypharmacy and Drug Adherence in Elderly Patients. Manouchehr Saljoughian, PharmD, PhD. Department of Pharmacy, Alta Bates ...
Polypharmacy - when patients are prescribed more than one drug at a time - is known to increase potential drug harms, reduce ... The study was published in the journal Aging and Disease, under the title "Identifying Dynamic Patterns of Polypharmacy for ... "Given the rise in dementia cases internationally, the need to understand how patterns of polypharmacy evolve before and after a ... Investigators explored the association of polypharmacy and dementia. They found that the proportion of people taking three or ...
Tag Archives: polypharmacy in preschoolers. CCHR Increases Watchdog Role of Antipsychotic Use in 830,000 Children and Teens New ...
Polypharmacy is a challenge, increasing risk for xerostomia and dental caries. It results in the need for fluoride therapies ... Polypharmacy and xerostomia. We often think of polypharmacy in association with elderly adult groups. However, it is also ... Polypharmacy and xerostomia are reported to be common in adults ages 45 to 64 years-of-age, with more than half of individuals ... Polypharmacy - defined as a medication count of five or more medications - further increases the likelihood of patients ...
A year ago today, our youngest child died, thanks to the adversarial actions and toxic treatments foisted on her by medical-model psychiatry. By telling her story, we hope to promote systemic change ...
Polypharmacy means taking many medicines. Older adults or people with long-term (chronic) diseases often need to do this. ... What is polypharmacy?. Polypharmacy means taking many medicines. Older adults or people with long-term (chronic) diseases often ...
... learn the signs and risk factors of polypharmacy to protect the health and safety of your senior living residents. ... Polypharmacy in Senior Living. June 6, 2023 Polypharmacy can be particularly dangerous for seniors - it can reduce quality of ... By understanding the signs and risk factors, senior living communities can help prevent polypharmacy and protect residents ...
Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties. Peter Hanlon, Terence J. Quinn, Katie I. ... Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties. Peter Hanlon, Terence J. Quinn, Katie I. ... Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties Message Subject (Your Name) has sent you ... Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties. Peter Hanlon, Terence J. Quinn, Katie I ...
Polypharmacy - The use of multiple drugs administered to the same patient, most commonly seen in elderly patients. ... ... Since in the United States most drugs are dispensed as single-agent formulations, polypharmacy, though using many drugs ... POLYPHARMACY \pˌɒlɪfˈɑːməsi], \pˌɒlɪfˈɑːməsi], \p_ˌɒ_l_ɪ_f_ˈɑː_m_ə_s_i]\ ...
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995-2010. BMC Med2015;13:74. doi: ... Polypharmacy is common in older adults, particularly those aged 65 or older, and, despite not always being avoidable, often ... Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev2018;9:CD008165.pmid: ... Polypharmacy is common in older people, often inappropriate, and associated with potential harms, yet no ideal strategy for ...
Disclaimer: The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this web site is for general information purposes only. Click here for Privacy Policy. ...
... active polypharmacy, according to a study published in the March 9 issue of the Journal of the American Medical Association. ... Of the participants, 13.9 percent met the criterion for CNS-active polypharmacy (32,139,610 polypharmacy-days of exposure). The ... CNS-active polypharmacy was defined as exposure to three or more medications for longer than 30 days from the following drug ... Of those with CNS-active polypharmacy, 57.8 and 6.8 percent were exposed for longer than 180 days and for 365 days, ...
Learn how polypharmacy can affect incontinence and the different treatment options available to adults with both conditions. ... The Risk of Polypharmacy. In the United States, more and more adults are considered polypharmacy patients. Approximately 31% of ... First, well discuss polypharmacy and incontinence, and then look at the risk of polypharmacy, and the consequences of ... Consequences of Polypharmacy. The most obvious consequence of polypharmacy is drug interactions and side effects. When multiple ...
Geriatric Cardiology Research Spotlight: Polypharmacy and Deprescribing in HF. February 6, 2021 10:00 AM - 11:00 AM iCal ... YOU ARE HERE: Home , Education and Meetings , Meetings , Geriatric Cardiology Research Spotlight: Polypharmacy and ... as he describes his research program on polypharmacy and deprescribing. Goyal will also discuss his career trajectory, with a ...
Keywords: antipsychotic polypharmacy, first generation antipsychotics, schizophrenia, second generation antipsychotics JOURNAL ... Purpose: Antipsychotic polypharmacy has been utilized frequently in the clinical setting despite lack of evidence for its ... we examined the current state of antipsychotic polypharmacy and the use of excessive doses in outpatients with schizophrenia. ... University Hospital of the proper use of antipsychotics has resulted in a reduced prevalence of antipsychotic polypharmacy and ...
Safe Medication Use & Minimizing Polypharmacy. March 26, 2019 @ 5:30 pm - 7:00 pm. Free ...
Increasing trends in multimorbidity and polypharmacy over a 5-year period in people living with HIV in the United States - Big ... As PWH age their slope of decline in function & slope of increase in comorbidities & polypharmacy is worse compared to HIV- ... Increasing trends in multimorbidity and polypharmacy over a 5-year period in people living with HIV in the United States. ... For the multimorbidity and polypharmacy analyses, numbers of people in each annual cohort were 14,222 in 2014, 14,527 in 2015, ...
Polypharmacy was defined as taking five or more medications. Associations of polypharmacy with occurrence of loneliness and ... Polypharmacy was defined as taking five or more medications. Associations of polypharmacy with occurrence of loneliness and ... Polypharmacy was defined as taking five or more medications. Associations of polypharmacy with occurrence of loneliness and ... Polypharmacy is increasing. The longitudinal association of polypharmacy and social isolation has not been previously reported ...
Classcodes for the comorbidity-polypharmacy score (CPS) based on ICD-10 codes ... Classcodes for the comorbidity-polypharmacy score (CPS) based on ICD-10 codes. Source: R/manual_for_datasets.R. cps.Rd. ... "Comorbidity polypharmacy score and its clinical utility: A pragmatic practitioners perspective." Journal of emergencies, ... Classcodes for the comorbidity-polypharmacy score (CPS) based on ICD-10 codes ...
Polypharmacy definition and medication counting. The number of medications at which polypharmacy is diagnosed varies widely ... polypharmacy. Observational studies have shown associations between polypharmacy and adverse events such as hospitalisations ... Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 Diabetes. JAMA 2016;315:1034-45.doi ... we lack both a consensus definition of polypharmacy3 and reliably reproducible tools to decrease polypharmacy and improve ...
Both speakers provided a powerful reminder of the problem of inappropriate polypharmacy, the harms associated with medicines ...
P50 The prevalence and determinants of polypharmacy: data from the british 1946 birth cohort ... P50 The prevalence and determinants of polypharmacy: data from the british 1946 birth cohort ...
Tackling the dangers of polypharmacy through big data analytics and pharmacoepidemiology ... "Polypharmacy is not dangerous perse, however, patients could be harmed if the right drug combinations are not used. We hope ... "With a rapidly aging population who are burdened with multiple chronic conditions, polypharmacy is bound to rise," said Dr. ... Taking more than one medication, also known as polypharmacy, can increase the risk for consequential drug interaction and ...
Antipsychotic Polypharmacy in Elderly Patients. Author(s): *Pharmacy Service, Galdakao-Usansolo Hospital, Barrio Labeaga s/n, ... These risks are boosted when geriatric population and high dosage derived from polypharmacy are considered. In this concern, ... Although some theoretical bases have been suggested supporting this practice known as antipsychotic polypharmacy (APP), there ... Antipsychotic Polypharmacy in Elderly Patients, Psychopharmacological Issues in Geriatrics (2015) 1: 287. https://doi.org/ ...
Results Age and number of health conditions account for the greatest odds of polypharmacy. ORs (95% CI) were greatest for those ... Thus, delaying or preventing the onset of long-term conditions may help to reduce polypharmacy. Interventions to reduce income ... Socioeconomic and health factors related to polypharmacy and medication management:analysis of a Household Health Survey in ... Objectives To examine the socioeconomic and demographic drivers associated with polypharmacy (5-9 medicines), extreme ...
Polypharmacy in elderly patients increases risk of adverse drug events, which can cause health and functional impairment, ... Polypharmacy in elderly patients increases risk of adverse drug events, which can cause health and functional impairment, ... Maness, Caleb P., "Improving Polypharmacy and Medication Review in the Elderly" (2023). Family Medicine Clerkship Student ...
Polypharmacy in the Newsroom of Cedars-Sinai Medical Center ... Cedars-Sinai Newsroom (Polypharmacy) RSS feed - Cedars-Sinai ...

No FAQ available that match "polypharmacy"